MedTrace Logo

Characteristics of COVID-19 Patients in Kazakhstan in Early 2020

NCT04627194 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-11-13

No results posted yet for this study

Summary

The aim of this study is to assess the epidemiological and clinical features of patients diagnosed with COVID-19 in Kazakhstan at the onset of the pandemic.

Conditions

  • Covid19
  • Pneumonia, Viral

Sponsors & Collaborators

  • Semey State Medical University

    lead OTHER

Principal Investigators

  • Yersin Zhunussov, MD, D.M.S. · Semey State Medical University

  • Raifa Ivanova, MD, D.M.S. · Semey State Medical University

  • Maiya Goremykina, M.D, C.M.S · Semey State Medical University

  • Sergey Yegorov, Ph.D. · Nazarbayev University, School of Sciences and Humanities

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-20
Primary Completion
2020-04-30
Completion
2020-12-01

Countries

  • Kazakhstan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04627194 on ClinicalTrials.gov